Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
paroxysmal nocturnal hemoglobinuria
Biotech
ASH: AstraZeneca shows longer term benefits of next-gen PNH drug
The week after Novartis secured a foothold in the PNH market, AstraZeneca has released longer-term data from danicopan.
James Waldron
Dec 11, 2023 5:58am
AstraZeneca pays $185M to reenter obesity race, drops SCD drug
Nov 9, 2023 5:00am
Novartis ups the ante in AstraZeneca blood disorder showdown
Apr 26, 2023 9:45am
Roche matches AstraZeneca's rare disease blockbuster in phase 3
Feb 7, 2023 6:10am
ASH: Roche records rare disease win ahead of Soliris showdown
Dec 12, 2022 8:15am
Novartis takes another swipe at AstraZeneca's rare disease gems
Dec 8, 2022 10:28am
